Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.195 USD | -0.12% | +0.12% | -21.91% |
Apr. 30 | Ladenburg Thalmann Starts Marker Therapeutics With Buy Rating, $11 Price Target | MT |
Mar. 27 | North American Morning Briefing : Stocks Edge -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.91% | 37.44M | |
+24.64% | 48.09B | |
+46.90% | 40.62B | |
-3.17% | 40.43B | |
-6.20% | 28.36B | |
+9.39% | 24.89B | |
-20.36% | 19.01B | |
+28.59% | 12.09B | |
+0.64% | 11.88B | |
-1.21% | 11.8B |
- Stock Market
- Equities
- MRKR Stock
- News Marker Therapeutics, Inc.
- Marker Therapeutics : Piper Sandler Starts Marker Therapeutics at Overweight with $6 Price Target